Date
...
Upcoming OOO |
|
|
HL7 FHIR Profile: Skin and Wound Assessment, Release 1 (For Comment) | Andrea | Background in the Proposal: Skin and Wound Assessment - FHIR - Confluence (hl7.org) There was a vendor that created a FHIR App that apparently is used. While not specific about pathology there was much discussion on how to document "landmarks" on the body like moles, tattoos, etc in relation to wound location. Conceivably, if a wound culture was performed, the specimen source site info would overlap with wound details. Pathology specimens would have similar needs. There are various refsets, value sets and SCT extensions listed. It was mentioned it should align with laboratory and pathology specimen information, but I haven't reviewed the codes/terms. Not sure if anything they developed would fill any CMT gaps or already contained therein? Mitre did a lot of the work on this too. Discussion: Looking at the FHIR IG - will need to review the valuesets for the LOINC components that describe the bodysite, since they removed observation.bodysite = https://loinc.org/39135-9 wounds require good documentation of where the sample was collected |
Questions about bite wounds from CSTE | Manjula | Came from CSTE data standardization working group for lab reporting data - described the specimen CMT project in the chat - were discussing use of US edition rather than international edition Nancy Barret (CT) noticed they got a lot of “junk” in the lab - asked about rules of collecting wound samples requested presentation about correct way to collect wound samples to the ELR National Working Group - this is an education issue of the clinicians (at minimum need to have the description, ideally it will be propery codified); CMT has guidelines on the collection for wounds, but a behavior chane is what is needed (maybe frame as cost issue / patient safety / outcome issue - increased antibiotic resistance) should we include specimen CMT info or just share the SHIELD presentation as background? Biggest issue is that we need to make the CMT available in a usable form Manjula can present the CMT piece (brief), Riki is usually on that call, so can help, main focus should be around the best specimen collection |
HTI-2 rule question | Andrea | Could specimen collection be on the radar for the federal agency that enforces the HIT certification pieces? this is broader than PH reporting / affects ALL lab tests also goes into specimen condition / reject reason for quality assessments; include competency testing (for techique that could be re-taught, but time allocation is more problematic) |
specimen condition and reject reason work | Here is the confluence page where OO is tracking this project: https://confluence.hl7.org/display/OO/Specimen+Condition+and+Specimen+Reject+Reason+Vocabulary Next step is to review against the concepts in #1 Standard PREanalytical Code Version 4.0 - (version 3.0 is here: https://cdn.ymaws.com/www.isber.org/resource/resmgr/isber_2019/pdf/standard_preanalytical_code_.pdf) maybe consider using this (if so, HL7 would need joint copyright or something) and also #2 international standard for biobanking: the ISO 20387:2018 - is anyone member and has access?
#3 ISBER BP5 for information regarding 'Specimen Reject Reason' | |
Previous Action Items |
|
|
Specimen CMT - review of terms with questions |
| |
Specimen CMT pilot implementers |
|
|
Specimen CMT - Hosting Options |
|
|
Specimen CMT - education |
|
|
Specimen CMT - tracking implementation impact
|
|
|
Specimen CMT - Compare to NHS Medical Terminology testing |
|
|
LOINC to SNOMED CT mapping |
|
|
Future projects for this call after CMT |
|
|
...
Andrea Pitkus to Everyone 11:55 AM
"evidence in the medical record that there is intent to place an order."
https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=59741&ver=2&bc=0
Recording:
https://aphl.zoom.us/rec/share/Jk-HP-139S_co7EYgV0z6bQmJNWSqXFlr6tdLdJJmZjhDLZmhJFq5ISew9eevrYC.81K-ftBoOeNcZZlC
Passcode: E.qC?d8Z
Action items
Quick decisions not requiring context or tracking
...